Blue-yellow colour vision in an onchocercal area of northern Nigeria

British Journal of Ophthalmology

Volumn 82, Issue 5, 1998, Pages 510-516

  Landers, A ^a   Murdoch, I E ^a,b   Birch, J ^c   Cousens, S N ^d   Babalola, O E ^b   Lawal, B ^e   Abiose, A ^b,e   Jones, B R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b AHMADU BELLO UNIVERSITY   (Nigeria)

^c CITY UNIVERSITY   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e National Eye Centre   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; COLOR VISION; COMPREHENSION; DIAGNOSTIC VALUE; FEMALE; GLAUCOMA; HUMAN; MALE; NIGERIA; OBSERVER VARIATION; ONCHOCERCIASIS; OPTIC NERVE ATROPHY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RURAL POPULATION; SCREENING; VISION TEST; VISUAL ACUITY;

EID: 0031782719     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.5.510     Document Type: Article

References (29)

1. Wright WD. The characteristics of tritanopia. J Soc Am 1952;42:509-21.
2. Van Norren D, Went LN. New test for tritan defects evaluated in two surveys. Vis Res 1981;21:1303-6.
3. Kalmus H. The familial distribution of congenital tritanopia. Ann Hum Genet 1955;20:39-56.
4. Went LN, Pronk N. The genetics of tritan disturbances. Hum Genet 1985;69:255-62.
5. Henry GH, Cole BL, Nathans J. The inheritance of congenital tritanopia with the report of an extensive pedigree. Ann Hum Genet 1964;27:219-31.
6. Weale RA. Age and the transmittance of the human crystalline lens. J Physiol 1988;395:577-87.
7. Verriest G, van Laetham J, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100 hue scores. Am J Ophthalmol 1982;93:635-42.
8. Krill AE, Smith VC, Pokorny J. Similarities between congenital tritan defects and dominant optic atrophy; coincidence or identity? J Opt Soc Am 1970;60:1132-9.
9. Gündüz K, Arden GB, Perry S, et al. Colour vision defects in ocular hypertension and glaucoma. Arch Ophthalmol 1988;106:929-35.
10. François J, Verriest G. Les dychromatopsies acquises. Ann Ocul (Paris) 1957;190:713-46.
11. Green FD, Ghafour JM, Allan D, et al. Colour vision of diabetics. Br J Ophthalmol 1985;69:533-6.
12. Birch J, Tertuik K, North F. Tritan screening with a modified TNO test. In: Verriest G, ed. Colour vision deficiences VIII. Dordrecht, Netherlands: Martinus Nijhoff/Dr W Junk Publishers 1987:227-32.
13. Birch J, Ariffin AE, Kurtz A. Colour vision screening for the detection of diabetic retinopathy. In: Drum B, Moreland JD, Serra A, eds. Colour vision deficiencies. Dordrecht, Netherlands: Kluwer Academic Publishers 1991:507-10.
14. Neuhann T, Kalmus H, Jaeger W. Ophthalmological findings in the tritans described by Wright and Kalmus. In: Verriest G, ed. Mod Probl Ophthalmol 17. Basle: Karger, 1976:135-42.
15. Abiose A, Jones BR, Cousens SN, et al. Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet 1993;341:130-4.
16. Abiose A, Murdoch I, Babalola O, et al. Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Br J Ophthalmol 1994;78:8-13.
17. Murdoch I. The epidemiology of glaucoma and glaucoma related parameters in rural communities mesoendemic and nonendemic for onchocerciasis, Kaduna State, Northern Nigeria. MD thesis University of London 1993.
18. Birch J. In: Diagnosis of defective colour vision. Oxford: Oxford University Press, 1993: 84.
19. Bird AC, El-Sheikh H, Anderson J, et al. Changes in visual function in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate. Br J Ophthalmol 1980;64:191-200.
20. Murdoch I. People and eyes - statistical pitfalls in ophthalmology. MSc thesis. London: London School of Hygiene and Tropical Medicine, University of London, 1995.
21. Cousens SN, Yahaya H, Murdoch I, et al. Risk factors for optic nerve disease in communities mesoendemic for savannah onchocerciasis, Kaduna State, Nigeria. Trop Med Int Health 1991;2:89-98.
22. Wolf E, Kluxen G. Colour vision in a case of unilateral nuclear cataract. In: Verriest G, ed. Colour vision deficiences VII. The Hague: Dr W Junk Publishers 1984:343-8.
23. Cruz-Coke R, Varela A. Defective colour vision and alcoholism. Its association with colour blindness. Lancet 1966;ii:1282-4.
24. Fialkow PJ, Thuline HC, Fenster CF. Lack of association between cirrhosis and the common types of colour blindness. N Engl J Med 1966;275:584-7.
25. Mäntyjärvi M. Observations on the use of the Lanthony Tritan Album. In: Drum B, Verriest G, eds. Colour deficiencies IX. Dordrecht: Kluwer Academic Publishers, 1989: 487-93.
26. Heron G, Erskine NA, Farquharson E, et al. Colour vision screening in glaucoma; the tritan album and other simple tests. Ophthal Physiol Opt 1994;14:233-8.
27. Murdoch I, Jones BR, Babalola OE, et al. Red dot card test of the para-central field as a screening test for optic nerve disease in onchocerciasis. Bull World Health Organ 1996;74: 573-6.
28. Birch J. Clinical use of a new pseudoisochromatic test for tritan colour deficiency. Optom Vis Sci 1993;70:30.
29. Birch J. In: Diagnosis of defective colour vision. Oxford: Oxford University Press, 1993:65-7 and 105-7.